Evidence map›Paper›PMID 41828571›Full record

ArticleInternational journal of molecular sciences2026

Atherogenic Lipoprotein Burden, Metabolic Stress and Immune Activation Associated with Coronary Atherosclerosis in Patients with Psoriasis.

Lazar Djukanovic, Dusan Skiljevic, Milos Nikolic, Marija Malinic, Svetlana Popadic, Oliver Radmili, Vladimir Cvetic, Nina Rajovic, Natasa Milic, Lidija Savic and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lazar DjukanovicDepartment of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-8841-8724
Dusan SkiljevicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-1475-487X
Milos NikolicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-3926-5394
Marija MalinicClinic of Dermatology and Venereology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-1021-2053
Svetlana PopadicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-5491-8509
Oliver RadmiliClinic for Vascular and Endovascular Surgery, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Vladimir CveticFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-7868-7880
Nina RajovicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Natasa MilicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Lidija SavicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-7526-1641
Lidija MaslacDepartment of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0009-0003-5777-7363
Milika AsaninFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Sanja StankovicCenter for Medical Biochemistry, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-0890-535X
Ratko LasicaFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-9033-5995

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a chronic inflammatory disease associated with an increased cardiovascular risk (CVR). The mechanisms linking psoriasis to coronary atherosclerosis have not yet been fully elucidated. A dynamic interplay between metabolic disturbances, immune mechanisms, and elevated atherogenic lipoprotein particles may contribute to the accelerated development of atherosclerosis. Patients with psoriasis (

Indexed as

AtherosclerosisCoronary Artery DiseaseLipoproteinsPsoriasisStress, PhysiologicalBiomarkersFemaleHumansImmunoglobulin AMaleMiddle AgedRisk FactorsBiomarkersImmunoglobulin ALipoproteinsatherosclerosisimmunoglobulin Ametabolic syndromepsoriasisremnant cholesterol

Identifiers

PMID41828571
PMCPMC12986232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.